Mount, G R <br/><br/>
Emerging biological therapies in systemic lupus erythematosus.  [electronic resource] 

 -  Clinical pharmacology and therapeutics  Jan 2008 
 - 167-71 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1532-6535 
<br/><br/><label>Standard No.: </label>10.1038/sj.clpt.6100436  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--adverse effects<br/>Antigens, CD--immunology<br/>Antigens, CD20--immunology<br/>Antigens, Differentiation--immunology<br/>B-Cell Activating Factor--antagonists & inhibitors<br/>Biological Therapy--trends<br/>CD11a Antigen--immunology<br/>CD40 Ligand--antagonists & inhibitors<br/>CTLA-4 Antigen<br/>Humans<br/>Immunosuppressive Agents--adverse effects<br/>Lupus Erythematosus, Systemic--drug therapy<br/>Patient Selection<br/>Prognosis<br/>Sialic Acid Binding Ig-like Lectin 2--immunology<br/>Tumor Necrosis Factor-alpha--antagonists & inhibitors